Temtokibart
Temtokibart is a humanized IgG1λ2 antibody targeting IL22RA1. Temtokibart can be used for moderate-to-severe atopic dermatitis study[1].
Product Specifications
CAS Number
[2639874-57-8]
Product Name Alternative
ARGX-112; LEO-138559; LP-0145
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/temtokibart.html
Purity
99.23
Solubility
10 mM in DMSO
Smiles
[Temtokibart]
Molecular Weight
(142.08 kDa)
References & Citations
[1]LEO Pharma presents two late-breaking abstracts for temtokibart reporting positive Phase 2b efficacy, safety and biomarker results in moderate-to-severe atopic dermatitis at the 2025 EADV Annual Meeting in Paris.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
